International Patent: SIRNA CONJUGATE TARGETING ANGPTL4 AND USE THEREOF

GENEVA, June 19 -- LEADERNA THERAPEUTICS, LTD filed a patent application (CN2025/135743) for “SIRNA CONJUGATE TARGETING ANGPTL4 AND USE THEREOF”. With publication no. WO/2026/103928, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....